Charles Schwab’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-472,129
Closed -$8.49M 3394
2020
Q2
$8.49M Buy
472,129
+19,653
+4% +$354K ﹤0.01% 1742
2020
Q1
$3.23M Buy
452,476
+7,611
+2% +$54.3K ﹤0.01% 2058
2019
Q4
$10.6M Buy
444,865
+12,821
+3% +$306K 0.01% 1642
2019
Q3
$11.6M Buy
432,044
+37,523
+10% +$1.01M 0.01% 1511
2019
Q2
$10.7M Buy
394,521
+16,028
+4% +$435K 0.01% 1557
2019
Q1
$13.1M Buy
378,493
+19,841
+6% +$688K 0.01% 1413
2018
Q4
$7M Sell
358,652
-1,884
-0.5% -$36.8K 0.01% 1695
2018
Q3
$9.6M Buy
360,536
+17,105
+5% +$456K 0.01% 1670
2018
Q2
$13M Buy
343,431
+35,818
+12% +$1.35M 0.01% 1412
2018
Q1
$10M Buy
307,613
+12,171
+4% +$398K 0.01% 1490
2017
Q4
$14.4M Buy
295,442
+24,971
+9% +$1.22M 0.01% 1232
2017
Q3
$14.6M Buy
270,471
+42,284
+19% +$2.28M 0.01% 1147
2017
Q2
$12.8M Buy
228,187
+6,964
+3% +$391K 0.01% 1174
2017
Q1
$8.67M Buy
221,223
+12,270
+6% +$481K 0.01% 1409
2016
Q4
$4.69M Buy
208,953
+30,171
+17% +$677K 0.01% 1777
2016
Q3
$4.06M Sell
178,782
-10,042
-5% -$228K ﹤0.01% 1784
2016
Q2
$4.46M Buy
188,824
+3,570
+2% +$84.3K 0.01% 1635
2016
Q1
$3.78M Buy
185,254
+4,039
+2% +$82.4K 0.01% 1689
2015
Q4
$9.32M Buy
181,215
+18,428
+11% +$948K 0.01% 1079
2015
Q3
$6.94M Buy
162,787
+8,750
+6% +$373K 0.01% 1236
2015
Q2
$7.02M Buy
154,037
+8,137
+6% +$371K 0.01% 1312
2015
Q1
$5.54M Buy
145,900
+35,316
+32% +$1.34M 0.01% 1438
2014
Q4
$3.13M Buy
110,584
+19,535
+21% +$553K ﹤0.01% 1753
2014
Q3
$2.3M Buy
91,049
+29,514
+48% +$746K ﹤0.01% 1882
2014
Q2
$1.8M Buy
61,535
+36,456
+145% +$1.06M ﹤0.01% 2032
2014
Q1
$650K Buy
25,079
+4,240
+20% +$110K ﹤0.01% 2486
2013
Q4
$537K Buy
20,839
+648
+3% +$16.7K ﹤0.01% 2566
2013
Q3
$550K Buy
20,191
+873
+5% +$23.8K ﹤0.01% 2513
2013
Q2
$467K Buy
+19,318
New +$467K ﹤0.01% 2551